An evaluation of efficacy for blood flow and cold intolerance of test food intake. - A placebo-controlled, randomized, double-blind cross-over clinical trial
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000046806
- Lead Sponsor
- IMEQRD Co., Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Not provided
1.Those who have been currently visiting a hospital or treated with any drug or herbal remedy for any disease 2.Those who are on diet/exercise therapy under the guidance of a doctor 3.Those who currently have or have history of severe diseases 4.Those who have serious anemia 5.Those who daily take medicine, quasi-medicine, food for specified health uses or nutritional supplements / foods on the market that have health claims related to fatigue, stress relief, cold intolerance, blood flow, blood pressure or calefacient (excluding individuals who can refrain from ingestion after receiving informed consent until the end of the study) 6.Those who are using any machine related to fatigue, stress relief, cold intolerance, blood flow, blood pressure or calefacient (excluding individuals who can refrain from the use after the informed consent until the end of the study) 7.Those who currently have or have a history of drug and/or food allergies 8.Those who have smoked within a year 9.Males who have donated more than 400 mL of the blood within 3 months before receiving informed consent 10.Females who have donated more than 200 mL of the blood within 3 months before receiving informed consent 11.Those who have plans of major change on their lifestyle (e.g., diet, sleep and exercise) during the study period 12.Those who have daily exercise such as jogging and muscle training 13.Those who are engaged in night work or spilt shift 14.Those who are planning to travel abroad during the study period 15.Those who are currently pregnant, breastfeeding or planning to get pregnant during the study period. 16.Those who joined other clinical trials since 1 month before receiving informed consent in this study, or those who are currently joining other clinical trials 17.Those who are judged by the physician to be unsuitable for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood flow
- Secondary Outcome Measures
Name Time Method Body surface temperature Questionnaire for subjective evaluation